METHOD FOR SELECTING ANTIBODY FRAGMENTS, RECOMBINANT ANTIBODIES PRODUCED THEREFROM, AND USES THEREOF IN DIAGNOSING AFRICAN SWINE FEVER VIRUS
Updated time: 2022-05-26 08:42:54
METHOD FOR SELECTING ANTIBODY FRAGMENTS, RECOMBINANT ANTIBODIES PRODUCED THEREFROM, AND USES THEREOF IN DIAGNOSING AFRICAN SWINE FEVER VIRUS
Docket Number
28A-1090915
Announcement Date
2021-01-15
IP Status
TW patent filing(111118917)、PCT filing (PCT/US22/30318)
Abstract
The invention is methods for selecting an antibody fragment specific to African swine fever virus (ASFV). Also disclosed herein are recombinant antibodies produced from the selected antibody fragments, and uses thereof in the diagnosis and treatment of ASFV infection.
Technological Advantages
- The antibody screening is in-vitro system which can produce multiple antibodies at the same time.
- The screening system is optimized for lateral flow devices.
- Antibodies can be further optimized if necessary.
Applications of Technology
- Applications of Africa swine fever virus antigen LFIA
- Applications of Africa swine fever virus antigen ELISA
Inventor
An-Suei Yang, Chung-Ming Yu, Chao-Ping Tung, Horng-Ru Hsu, Hung-Pin Peng, Chi-Yung Chen, Yu-Chuan Huang, Pei-Hsun Tsai, Szu-Yu Lin, Fei-Hung Hung.
Contact person
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Request for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office

METHOD FOR SELECTING ANTIBODY FRAGMENTS, RECOMBINANT ANTIBODIES PRODUCED THEREFROM, AND USES THEREOF IN DIAGNOSING AFRICAN SWINE FEVER VIRUS